Dachser renews IATA CEIV pharma certification in Frankfurt

Dachser’s Frankfurt air and sea freight branch has once again received certification from IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma), demonstrating its capabilities in logistics services for the lifescience and healthcare industry.

In a statement, Dascher said that the transport of lifescience and healthcare products must meet exacting standards. Drugs and other pharmaceutical products are often temperature-sensitive, urgent shipments that must be handled in compliance with a complex regulatory environment. As an industry standard, CEIV pharma certification covers the specific requirements of senders of pharmaceutical products with regard to safe, correct and efficient air freight services.

“This recertification confirms our expertise in the lifescience and healthcare sector,” said Timo Stroh, Head, Global Air Freight, who is also responsible for the lifescience and healthcare logistics business field solution at Dachser.

Stroh added, “It certifies the highest standards of service and quality, which we provide to our customers through consistent processes and a GDP-compliant network.”

The same standards apply for recertification as for initial certification. CEIV pharma certification requires internal and external training, a review of procedures for handling temperature-controlled lifescience and healthcare shipments, and an extensive assessment of these complex processes by two independent auditors, the statement further said.

“We consider it absolutely essential to meet international standards in the worldwide transport of sensitive products,” Stroh explained.

“This benefits our customers. Our location at Frankfurt Airport is immensely important for our global network. As an international air freight gateway with its own charter connections, its direct link to Dachser’s tightly-knit overland transport network, and the established CEIV pharma setup, the location is crucial for the further development of our industry solution for customers in the life science and healthcare sector,” Stroh further said.